검색어 : 통합검색[Weber Mathias]
총 612건 중 612건 출력
, 56/62 페이지
-
551
- Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer
- Lisa Richters; Oleg Gluz; Nana Weber-Lassalle; Matthias Christgen; Heinz Haverkamp; Sherko Kuemmel; Mohamad Kayali; Ronald E. Kates; Eva-Maria Grischke; Janine Altmüller; Helmut Forstbauer; Holger Thiele; Michael Braun; Mathias Warm; Anna Ossowski; Rachel Wuerstlein; Corinna Ernst; Monika Graeser; Sabine C. Linn; Ulrike Nitz; Jan Hauke; Hans Heinrich Kreipe; Rita K. Schmutzler; Eric Hahnen; Nadia Harbeck; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Women’s Clinic and Breast Center, University Clinics Cologne, Cologne, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Institute of Pathology, Medical School Hannover, Hannover, Germany; Now with Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany; Department of Gynecology, Breast Center, Charité–Universitätsmedizin Berlin, Berlin, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; West German Study Group, Moenchengladbach, Germany; Women’s Clinic, University Clinics Tübingen, Tübingen, Germany; Core Unit Genomics, Berlin Institute of Health, Charité–Universitätsmedizin Berlin, Berlin, Germany; Oncology Practice Network, Troisdorf, Germany; Cologne Center for Genomics, University of Cologne, Cologne, Germany; Interdisciplinary Breast Center, Rotkreuz-Clinics Munich, Munich, Germany; Breast Center, Municipal Hospital Holweide, Cologne, Germany; Cologne Center for Genomics, University of Cologne, Cologne, Germany; Breast Center, Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital of Ludwig Maximilian University, Munich, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; West German Study Group, Moenchengladbach, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Institute of Pathology, Medical School Hannover, Hannover, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; Breast Center, Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital of Ludwig Maximilian University, Munich, Germany; (JAMA Network Open, v., 2025, )
-
552
- A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer
- Rad, Roland; Rad, Lena; Wang, Wei; Strong, Alexander; Ponstingl, Hannes; Bronner, Iraad F; Mayho, Matthew; Steiger, Katja; Weber, Julia; Hieber, Maren; Veltkamp, Christian; Eser, Stefan; Geumann, Ulf; Ö llinger, Rupert; Zukowska, Magdalena; Barenboim, Maxim; Maresch, Roman; Cadiñ anos, Juan; Friedrich, Mathias; Varela, Ignacio; Constantino-Casas, Fernando; Sarver, Aaron; ten Hoeve, Jelle; Prosser, Haydn; Seidler, Barbara; Bauer, Judith; Heikenwä lder, Mathias; Metzakopian, Emmanouil; Krug, Anne; Ehmer, Ursula; Schneider, Gü nter; Knö sel, Thomas; Rü mmele, Petra; Aust, Daniela; Grü tzmann, Robert; Pilarsky, Christian; Ning, Zemin; Wessels, Lodewyk; Schmid, Roland M; Quail, Michael A; Vassiliou, George; Esposito, Irene; Liu, Pentao; Saur, Dieter; Bradley, Allan; 1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universitä t Mü nchen, Mü nchen, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. [3] The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.; Department of Pathology, Klinikum Rechts der Isar, Technische Universitä t Mü nchen, Mü nchen, Germany.; 1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universit&aum; (Nature genetics, v.47, 2015, pp.47-56)
-
553
- The High Brilliance neutron Source (HBS): A project for a next generation neutron research facility
- Brü ckel, Thomas; Gutberlet, Thomas; Baggemann, Johannes; Chen, Junyang; Claudio-Weber, Tania; Ding, Qi; El-Barbari, Monia; Li, Jingjing; Lieutenant, Klaus; Mauerhofer, Eric; Rü cker, Ulrich; Schmidt, Norberto; Schwab, Alexander; Voigt, Jö rg; Zakalek, Paul; Bessler, Yannick; Hanslik, Romuald; Achten, Richard; Lö chte, Fynn; Strothmann, Mathias; Felden, Olaf; Gebel, Ralf; Lehrach, Andreas; Rimmler, Marius; Podlech, Holger; Meusel, Oliver; Ott, Fré dé ric; Menelle, Alain; Paulin, Mariano André s; ; (The European Physical Journal Conferences, v.286, 2023, pp.02003)
-
554
- Lymphotoxin β Receptor Signaling Promotes Development of Autoimmune Pancreatitis
- Seleznik, Gitta M.; Reding, Theresia; Romrig, Franziska; Saito, Yasuyuki; Mildner, Alexander; Segerer, Stephan; Sun, Li– Kang; Regenass, Stephan; Lech, Maciej; Anders, Hans– Joachim; McHugh, Donal; Kumagi, Teru; Hiasa, Yoichi; Lackner, Carolin; Haybaeck, Johannes; Angst, Eliane; Perren, Aurel; Balmer, Maria Luisa; Slack, Emma; MacPherson, Andrew; Manz, Markus G.; Weber, Achim; Browning, Jeffrey L.; Arkan, Melek Canan; Rü licke, Thomas; Aguzzi, Adriano; Prinz, Marco; Graf, Rolf; Heikenwalder, Mathias; Institute of Neuropathology, Zurich, Switzerland; Department of Surgery, Swiss Hepato-Pancreato-Biliary Center, University Hospital Zurich, Switzerland; Second Department of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; Division of Haematology, University Hospital Zurich, Switzerland; Department of Neuropathology & BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany; Division of Nephrology, University Hospital Zurich, Switzerland; Department of Surgery, Swiss Hepato-Pancreato-Biliary Center, University Hospital Zurich, Switzerland; Division of Clinical Immunology, University Hospital Zurich, Switzerland; Medizinische Klinik IV, Klinikum der Universitä t Mü nchen, Campus Innenstadt, Munich, Germany; Medizinische Klinik IV, Klinikum der Universitä t Mü nchen, Campus Innenstadt, Munich, Germany; Institute of Neuropathology, Zurich, Switzerland; Gastroenterology and Metabology, Ehime Univ; (Gastroenterology, v.143, 2012, pp.1361-1374)
-
555
- Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
- Hü tter-Krö nke, Marie-Luise; Benner, Axel; Dö hner, Konstanze; Krauter, Jü rgen; Weber, Daniela; Moessner, Margit; Kö hne, Claus-Henning; Horst, Heinz A.; Schmidt-Wolf, Ingo G.H.; Rummel, Mathias; Gö tze, Katharina; Koller, Elisabeth; Petzer, Andreas L.; Salwender, Hans; Fiedler, Walter; Kirchen, Heinz; Haase, Detlef; Kremers, Stephan; Theobald, Matthias; Matzdorff, Axel C.; Ganser, Arnold; Dö hner, Hartmut; Schlenk, Richard F.; Department of Internal Medicine III, University Hospital Ulm, Germany; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany; Department of Internal Medicine III, University Hospital Ulm, Germany; Department of Oncology and Hematology, Klinikum Braunschweig, Germany; Department of Internal Medicine III, University Hospital Ulm, Germany; Department of Internal Medicine III, University Hospital Ulm, Germany; Department of Oncology and Hematology, Klinikum Oldenburg, Germany; Department of Internal Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Germany; Department of Internal Medicine III, CIO, University Hospital of Bonn, Germany; Department of Hematology/Oncology, University-hospital Giessen, Germany; Department of Internal Medicine III, Technical University of Munich, Germany; Department of Hematology/Oncology, Hanuschkrankenhaus, Wien, Austria; Department of Medical Oncology and Hematology, Krankenhaus der Barmherzigen Schwestern,; (Haematologica, v.101, 2016, pp.839-845)
-
556
- Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
- Jarius, Sven; Pellkofer, Hannah; Siebert, Nadja; Korporal-Kuhnke, Mirjam; Hü mmert, Martin W.; Ringelstein, Marius; Rommer, Paulus S.; Ayzenberg, Ilya; Ruprecht, Klemens; Klotz, Luisa; Asgari, Nasrin; Zrzavy, Tobias; Hö ftberger, Romana; Tobia, Rafik; Buttmann, Mathias; Fechner, Kai; Schanda, Kathrin; Weber, Martin; Asseyer, Susanna; Haas, Jü rgen; Lechner, Christian; Kleiter, Ingo; Aktas, Orhan; Trebst, Corinna; Rostasy, Kevin; Reindl, Markus; Kü mpfel, Tania; Paul, Friedemann; Wildemann, Brigitte; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany; Department of Neurology, Charité - Universitä tsmedizin Berlin, Berlin, Germany; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany; Department of Neurology, Medical Faculty, Heinrich Heine University, Dü sseldorf, Germany; Institute of Neurology, Medical University of Vienna, Vienna, Austria; Department of Neurology, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany; Department of Neurology, Charité - Universitä tsmedizin Berlin, Berlin, Germany; Department of Neurology with Institute of Translational Neurology, University Hospital Mü nster, Mü nster, Germany; Department of R; (Journal of neuroinflammation, v.17, 2020, pp.261)
-
557
- Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T<sub>H</sub>17 differentiation
- Jeltsch, Katharina M; Hu, Desheng; Brenner, Sven; Zö ller, Jessica; Heinz, Gitta A; Nagel, Daniel; Vogel, Katharina U; Rehage, Nina; Warth, Sebastian C; Edelmann, Stephanie L; Gloury, Renee; Martin, Nina; Lohs, Claudia; Lech, Maciej; Stehklein, Jenny E; Geerlof, Arie; Kremmer, Elisabeth; Weber, Achim; Anders, Hans-Joachim; Schmitz, Ingo; Schmidt-Supprian, Marc; Fu, Mingui; Holtmann, Helmut; Krappmann, Daniel; Ruland, Jü rgen; Kallies, Axel; Heikenwalder, Mathias; Heissmeyer, Vigo; 1] Institute for Immunology, Ludwig-Maximilians-Universitä t Mü nchen, Munich, Germany. [2] Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute for Virology, Technische Universitä t Mü nchen/Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute of Toxicology and Pharmacology, Research Unit Cellular Signal Integration, Helmholtz Zentrum Mü nchen, Neuherberg, Germany.; Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; 1] Institute for Immunology, Ludwig-Maximilians-Universitä t Mü nchen, Munich, Germany. [2] Institute of Molecular Immunology, Helmholtz Zentrum Mü nchen, Munich, Germany.; Institute of Molecular Immun; (Nature immunology, v.15, 2014, pp.1079-1089)
-
558
- Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
- Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mä urer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; Goebels, Norbert; Guger, Michael; Haghikia, Aiden; Hartung, Hans-Peter; Heidenreich, Fedor; Hoffmann, Olaf; Kallmann, Boris; Kleinschnitz, Christoph; Klotz, Luisa; Leussink, Verena I.; Leutmezer, Fritz; Limmroth, Volker; Lü nemann, Jan D.; Lutterotti, Andreas; Meuth, Sven G.; Meyding-Lamadé , Uta; Platten, Michael; Rieckmann, Peter; Schmidt, Stephan; Tumani, Hayrettin; Weber, Frank; Weber, Martin S.; Zettl, Uwe K.; Ziemssen, Tjalf; Zipp, Frauke; Klinik fü r Neurologie mit Institut fü r Translationale Neurologie, Universitä tsklinikum Mü nster, Albert-Schweitzer-Campus 1, Gebä ude A1, 48149 Mü nster; Neurologie, St. Josef-Hospital, Klinikum der Ruhr-Universitä t Bochum, Gudrunstraße 56, 44791 Bochum, Germany; Universitä tsklinik fü r Neurologie, Medizinische Universitä t Wien, Wien, Austria; Neurologische Klinik und Poliklinik, Universitä tsspital Basel, Basel, Switzerland; Klinik und Poliklinik fü r Neurologie, Universitä tsklinikum Regensburg, Regensburg, Germany; Neurologie und Neurologische Frü hrehabilitation, Klinikum Wü rzburg Mitte gGmbH, Standort Juliusspital, Wü rzburg, Germany; Neurologische Klinik, Heinrich-Heine-Universitä t Dü sseldorf, Dü sseldorf, Germany; Neurologie, Klinik Hennigsdorf, Hennigsdorf, Germany; Neurologie, Universitä tsklinikum Gießen, Gießen, Germany; Klinik fü r Neurologie, Universitä tsmedizin; (Therapeutic advances in neurological disorders, v.14, 2021, pp.17562864211039648)
-
559
- Outcomes and Impact of Device Iterations in Mitral Valve Transcatheter Edge-to-Edge Repair
- von Stein, Philipp; Stolz, Lukas; Haurand, Jean Marc; Grö ger, Matthias; Rudolph, Felix; Mustafa, Donika; Jobst, Jannik; Mues, Christoph Alexander; Mahabadi, Amir Abbas; Hö rbrand, Isabel A.; Schulz, Carl; Sugiura, Atsushi; Ruf, Tobias; Lurz, Philipp; Gerç ek, Muhammed; Horn, Patrick; Kessler, Mirjam; Rassaf, Tienush; Weber, Marcel; Kister, Tobias; Schofer, Niklas; Konstandin, Mathias; Schindhelm, Florian; Mö llmann, Helge; Unsö ld, Bernhard; Baldus, Stephan; Rottbauer, Wolfgang; Rudolph, Volker; Hausleiter, Jö rg; Pfister, Roman; Mauri, Victor; ; (JACC. Cardiovascular interventions, v.18, 2025, pp.573-586)
-
560
- No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens
- Baden David; Zukunft Sven; Hernández Gema; Wolgast Nadine; Steinhäuser Sophie; Pohlmann Alexander; Schliemann Christoph; Mikesch Jan-Henrik; Steffen Björn; Sauer Tim; Hanoun Maher; Schäfer-Eckart Kerstin; Krause Stefan; Hänel Mathias; Einsele Hermann; Jost Edgar; Brümmendorf Tim; Scholl Sebastian; Hochhaus Andreas; Neubauer Andreas; Burchert Andreas; Kaufmann Martin; Niemann Dirk; Schaich Markus; Blau Wolfgang; Kiani Alexander; Görner Martin; Kaiser Ulrich; Kullmer Johannes; Weber Thomas; University Hospital Schleswig-Holstein; University Hospital of TU Dresden; Biomedical Informatics Group, Universidad Politécnica de Madrid, Spain; University Medical Center Schleswig-Holstein; University Medical Center Schleswig-Holstein, Kiel; University Hospital Münster; University of Münster; Münster University; University Hospital, Goethe University; University Clinic Heidelberg, Heidelberg University; Essen University Hospital; Klinikum Nuernberg Nord; Universitätsklinikum Erlangen; Klinikum Chemnitz; University Hospital Würzburg; Universitaetsklinikum Aachen; RWTH Aachen University; Department of Internal Medicine II; Universitätsklinikum Jena; Philipps-University Marburg; Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg; Robert Bosch Hospital; Gemeinschaftsklinikum Mittelrhein gGmbH; Rems-Murr-Hospital; Helios Dr Schmidt Hospital Wiesbaden; Klinikum Bayreuth GmbH; Städtische Kliniken Bielefeld; St. Bernward Hospital; DIAKO Ev. Diakonie-Krankenhaus gemeinnützige GmbH; BMT section; (, v., 2024, )
QUICK MENU
